Stock 600566 HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
41.14 CNY +2.34% Intraday chart for Hubei Jumpcan Pharmaceutical Co., Ltd. -2.70% +30.89%
Apr. 19 Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,705 17,969 25,173 25,092 28,972 37,923 - -
Enterprise Value (EV) 1 19,705 17,969 25,173 25,092 28,972 37,923 37,923 37,923
P/E ratio 12.2 x 13.2 x 14.8 x 11.4 x 10.2 x 12.4 x 11.4 x 10 x
Yield 5.09% - - - - - - -
Capitalization / Revenue 2.84 x 2.91 x 3.3 x 2.79 x 3 x 3.78 x 3.34 x 3.24 x
EV / Revenue 2.84 x 2.91 x 3.3 x 2.79 x 3 x 3.78 x 3.34 x 3.24 x
EV / EBITDA - - 11.3 x 9.16 x 8.14 x 10.6 x 10.1 x 8.87 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 3.23 x 2.35 x 2.79 x 2.21 x 2.17 x 2.37 x 2.08 x 1.72 x
Nbr of stocks (in thousands) 814,922 888,257 888,259 921,822 921,807 921,807 - -
Reference price 2 24.18 20.23 28.34 27.22 31.43 41.14 41.14 41.14
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,940 6,165 7,631 8,996 9,655 10,042 11,369 11,709
EBITDA 1 - - 2,226 2,740 3,561 3,565 3,759 4,275
EBIT 1 1,858 1,469 1,933 2,423 3,258 3,504 3,816 4,344
Operating Margin 26.77% 23.83% 25.33% 26.94% 33.75% 34.9% 33.56% 37.1%
Earnings before Tax (EBT) 1 1,893 1,484 1,950 2,508 3,297 3,544 3,871 4,390
Net income 1 1,623 1,277 1,719 2,171 2,823 3,047 3,334 3,773
Net margin 23.39% 20.72% 22.53% 24.13% 29.24% 30.34% 29.32% 32.23%
EPS 2 1.990 1.530 1.910 2.390 3.080 3.307 3.618 4.097
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 1.230 - - - - - - -
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 28.4% 19.9% 20.5% 21.9% 23% 19% 18.3% 17.2%
ROA (Net income/ Total Assets) - - - - - 14.2% 13.8% 13.2%
Assets 1 - - - - - 21,458 24,159 28,586
Book Value Per Share 2 7.490 8.630 10.20 12.30 14.50 17.30 19.80 23.90
Cash Flow per Share 2 2.640 2.010 2.130 2.840 3.760 2.760 3.890 4.090
Capex 1 546 - - - - 306 271 255
Capex / Sales 7.86% - - - - 3.04% 2.38% 2.17%
Announcement Date 3/12/20 4/16/21 1/19/22 1/19/23 4/9/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hubei Jumpcan Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
41.14 CNY
Average target price
52.36 CNY
Spread / Average Target
+27.27%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. Stock Hubei Jumpcan Pharmaceutical Co., Ltd.
+30.89% 5.24B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+19.64% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.77% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.08% 235B
NOVARTIS AG Stock Novartis AG
+4.50% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.90% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600566 Stock
  4. Financials Hubei Jumpcan Pharmaceutical Co., Ltd.